SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-021266
Filing Date
2022-05-25
Accepted
2022-05-25 16:06:18
Documents
14
Period of Report
2022-05-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-8k_20220524.htm   iXBRL 8-K 32875
2 EX-99.1 mnkd-ex991_26.htm EX-99.1 49348
3 GRAPHIC gt0ly1um5okc000001.jpg GRAPHIC 8800
  Complete submission text file 0001564590-22-021266.txt   227705

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20220524.xsd EX-101.SCH 5605
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20220524_lab.xml EX-101.LAB 18565
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20220524_pre.xml EX-101.PRE 11047
8 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-8k_20220524_htm.xml XML 3401
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 22962927
SIC: 2834 Pharmaceutical Preparations